Arcturus Therapeutics Holdings Inc.
ARCTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Arcturus Therapeutics Holdings Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 8 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 15, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2026-03-31 | 34,302 | Not shown | SEC filing |
| Formidable Asset Management, LLC | 2026-03-31 | 10,600 | Not shown | SEC filing |
| NFSG Corp | 2026-03-31 | 40 | Not shown | SEC filing |
| D. E. Shaw & Co., Inc. | 2026-03-31 | 252,034 | Not shown | SEC filing |
| Quantinno Capital Management LP | 2026-03-31 | 71,353 | Not shown | SEC filing |
| HEARTLAND ADVISORS INC | 2026-03-31 | 256,000 | Not shown | SEC filing |
| Invesco Ltd. | 2026-03-31 | 113,570 | Not shown | SEC filing |
| Quadrature Capital Ltd | 2026-03-31 | 30,078 | Not shown | SEC filing |
| CITIGROUP INC | 2026-03-31 | 2,327 | Not shown | SEC filing |
| WELLS FARGO & COMPANY/MN | 2026-03-31 | 19,004 | Not shown | SEC filing |
| Jump Financial, LLC | 2026-03-31 | 68,293 | Not shown | SEC filing |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2026-03-31 | 198,728 | Not shown | SEC filing |
| HSBC HOLDINGS PLC | 2026-03-31 | 52,825 | Not shown | SEC filing |
| Covestor Ltd | 2026-03-31 | 12 | Not shown | SEC filing |
| Susquehanna Portfolio Strategies, LLC | 2026-03-31 | 64,396 | Not shown | SEC filing |
| ROYAL BANK OF CANADA | 2026-03-31 | 967 | Not shown | SEC filing |
| DIMENSIONAL FUND ADVISORS LP | 2026-03-31 | 288,355 | Not shown | SEC filing |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 2026-03-31 | 257 | Not shown | SEC filing |
| AMERICAN CENTURY COMPANIES INC | 2026-03-31 | 66,012 | Not shown | SEC filing |
| Inscription Capital, LLC | 2026-03-31 | 11,774 | Not shown | SEC filing |
- Each value is checked against Arcturus Therapeutics Holdings Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Arcturus Therapeutics Holdings Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2021-08-11 · Ultragenyx Pharmaceutical Inc.: Larger than 35 of the 38 other insider sales of Common Stock on file. SEC filing
- 2021-08-10 · Ultragenyx Pharmaceutical Inc.: Larger than all 38 other insider sales of Common Stock on file. SEC filing
- 2020-12-09 · Ultragenyx Pharmaceutical Inc.: Larger than 36 of the 38 other insider sales of Common Stock on file. SEC filing
- 2020-12-08 · Ultragenyx Pharmaceutical Inc.: Larger than 37 of the 38 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2020-06-10–2020-06-12: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2019-09-12–2019-09-13: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2019-08-23–2019-08-29: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2019-08-19–2019-08-23: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-15 (amended) | SASSINE ANDY · Chief Financial Officer | Common Stock | P — Open market or private purchase | +1,238 | 16.56 | SEC filing |
| 2025-08-15 | SASSINE ANDY · Chief Financial Officer | Common Stock | P — Open market or private purchase | −1,238 | 16.56 | SEC filing |
| 2024-10-15 | Chivukula Pad · Chief Scientific Officer & COO | Common Stock | S — Open market or private sale | −12,000 | 20.76 | SEC filing |
| 2024-06-12 | SASSINE ANDY · Chief Financial Officer | Common Stock | S — Open market or private sale | −50,000 | 32.03 | SEC filing |
| 2024-06-05 | Chivukula Pad · Chief Scientific Officer & COO | Common Stock | S — Open market or private sale | −114 | 45.00 | SEC filing |
| 2024-06-03 | Chivukula Pad · Chief Scientific Officer & COO | Common Stock | S — Open market or private sale | −26,000 | 40.01 | SEC filing |
| 2024-03-25 | Chivukula Pad · Chief Scientific Officer & COO | Common Stock | S — Open market or private sale | −17,435 | 35.02 | SEC filing |
| 2024-03-19 | Chivukula Pad · Chief Scientific Officer & COO | Common Stock | S — Open market or private sale | −8,565 | 35.01 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-05 | Marantz Jing L. · Director | Stock option (right to buy) | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-05 | Markels John · Director | Stock option (right to buy) | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-05 | Slaoui Moncef · Director | Stock option (right to buy) | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-05 | BARLOW JAMES F · Director | Stock option (right to buy) | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-05 | Marquet Magda · Director | Stock option (right to buy) | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-05 | FARRELL PETER C · Director | Stock option (right to buy) | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-05 | HOLMES EDWARD W · Director | Stock option (right to buy) | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-05-01 | MULROY DENNIS · Chief Financial Officer | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +100,000 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.